Real-time Estimate
Cboe BZX
01:22:51 2024-05-24 pm EDT
|
5-day change
|
1st Jan Change
|
101.2
USD
|
+1.20%
|
|
-0.43%
|
+11.84%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
33,186
|
26,966
|
37,333
|
30,974
|
49,906
|
59,768
|
-
|
-
|
Enterprise Value (EV)
1 |
48,189
|
39,162
|
51,195
|
44,890
|
63,648
|
73,490
|
74,968
|
75,952
|
P/E ratio
|
26.8
x
|
27.7
x
|
110
x
|
219
x
|
137
x
|
78.8
x
|
58.1
x
|
49.2
x
|
Yield
|
4.26%
|
4.18%
|
2.84%
|
3.72%
|
2.71%
|
2.47%
|
2.61%
|
2.76%
|
Capitalization / Revenue
|
6.48
x
|
5.85
x
|
7.87
x
|
5.29
x
|
7.52
x
|
7.67
x
|
6.95
x
|
6.08
x
|
EV / Revenue
|
9.41
x
|
8.5
x
|
10.8
x
|
7.66
x
|
9.59
x
|
9.43
x
|
8.71
x
|
7.72
x
|
EV / EBITDA
|
20.9
x
|
20.8
x
|
27.8
x
|
20.9
x
|
25.3
x
|
25.2
x
|
22.3
x
|
20.5
x
|
EV / FCF
|
54.5
x
|
42.6
x
|
89.1
x
|
-
|
-
|
128
x
|
54.2
x
|
42.3
x
|
FCF Yield
|
1.83%
|
2.35%
|
1.12%
|
-
|
-
|
0.78%
|
1.85%
|
2.36%
|
Price to Book
|
2.16
x
|
1.69
x
|
2.18
x
|
1.58
x
|
2.02
x
|
2.17
x
|
2.07
x
|
2.15
x
|
Nbr of stocks (in thousands)
|
405,800
|
417,305
|
435,275
|
472,521
|
553,469
|
597,916
|
-
|
-
|
Reference price
2 |
81.78
|
64.62
|
85.77
|
65.55
|
90.17
|
99.96
|
99.96
|
99.96
|
Announcement Date
|
2/12/20
|
2/9/21
|
2/15/22
|
2/15/23
|
2/13/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
5,121
|
4,606
|
4,742
|
5,861
|
6,638
|
7,792
|
8,605
|
9,833
|
EBITDA
1 |
2,305
|
1,880
|
1,841
|
2,151
|
2,511
|
2,913
|
3,357
|
3,713
|
EBIT
1 |
1,278
|
841.3
|
803.3
|
841.1
|
1,110
|
1,229
|
1,621
|
1,715
|
Operating Margin
|
24.95%
|
18.27%
|
16.94%
|
14.35%
|
16.72%
|
15.78%
|
18.84%
|
17.44%
|
Earnings before Tax (EBT)
1 |
542.9
|
-31.55
|
170.8
|
173.1
|
350
|
744.5
|
1,005
|
1,240
|
Net income
1 |
1,232
|
978.8
|
336.1
|
141.2
|
340.1
|
731.9
|
1,010
|
1,200
|
Net margin
|
24.06%
|
21.25%
|
7.09%
|
2.41%
|
5.12%
|
9.39%
|
11.74%
|
12.21%
|
EPS
2 |
3.050
|
2.330
|
0.7800
|
0.3000
|
0.6600
|
1.269
|
1.720
|
2.030
|
Free Cash Flow
1 |
883.7
|
918.4
|
574.8
|
-
|
-
|
572.4
|
1,384
|
1,795
|
FCF margin
|
17.25%
|
19.94%
|
12.12%
|
-
|
-
|
7.35%
|
16.08%
|
18.26%
|
FCF Conversion (EBITDA)
|
38.34%
|
48.86%
|
31.22%
|
-
|
-
|
19.65%
|
41.23%
|
48.35%
|
FCF Conversion (Net income)
|
71.7%
|
93.83%
|
170.99%
|
-
|
-
|
78.21%
|
136.98%
|
149.55%
|
Dividend per Share
2 |
3.480
|
2.700
|
2.440
|
2.440
|
2.440
|
2.470
|
2.607
|
2.756
|
Announcement Date
|
2/12/20
|
2/9/21
|
2/15/22
|
2/15/23
|
2/13/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
1,309
|
1,396
|
1,473
|
1,474
|
1,519
|
1,561
|
1,665
|
1,662
|
1,750
|
1,860
|
1,939
|
2,019
|
2,077
|
2,153
|
2,256
|
EBITDA
1 |
491
|
504.3
|
581.9
|
526.9
|
538.4
|
558.6
|
662.5
|
620.6
|
669.4
|
709.5
|
731.5
|
762.2
|
782.9
|
807.5
|
822.2
|
EBIT
1 |
206.5
|
200.2
|
271.6
|
173.2
|
196.1
|
219.5
|
320.6
|
281.3
|
288.6
|
343.6
|
332.1
|
348.5
|
367.5
|
419.2
|
-
|
Operating Margin
|
15.77%
|
14.35%
|
18.44%
|
11.75%
|
12.91%
|
14.06%
|
19.25%
|
16.93%
|
16.5%
|
18.48%
|
17.13%
|
17.26%
|
17.69%
|
19.47%
|
-
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-
|
-
|
-
|
38
|
152.3
|
72.24
|
87.46
|
140.9
|
182.8
|
196.2
|
216.4
|
213.9
|
236.4
|
Net income
1 |
58.67
|
61.92
|
89.78
|
-6.767
|
-3.728
|
25.67
|
103
|
127.5
|
83.91
|
127.1
|
184
|
206.2
|
208.7
|
217.7
|
228.7
|
Net margin
|
4.48%
|
4.44%
|
6.1%
|
-0.46%
|
-0.25%
|
1.64%
|
6.19%
|
7.67%
|
4.8%
|
6.84%
|
9.49%
|
10.22%
|
10.05%
|
10.11%
|
10.14%
|
EPS
2 |
0.1300
|
0.1400
|
0.2000
|
-0.0100
|
-0.0100
|
0.0500
|
0.2000
|
0.2400
|
0.1500
|
0.2200
|
0.3153
|
0.3468
|
0.3708
|
0.3900
|
0.3933
|
Dividend per Share
2 |
0.6100
|
0.6100
|
0.6100
|
0.6100
|
0.6100
|
-
|
0.6100
|
0.6100
|
0.6100
|
-
|
0.6100
|
0.6133
|
0.6167
|
0.6433
|
0.6500
|
Announcement Date
|
2/15/22
|
5/10/22
|
8/9/22
|
11/7/22
|
2/15/23
|
5/2/23
|
7/31/23
|
10/30/23
|
2/13/24
|
4/29/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
15,003
|
12,196
|
13,862
|
13,916
|
13,742
|
13,722
|
15,201
|
16,184
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
6.51
x
|
6.488
x
|
7.53
x
|
6.468
x
|
5.472
x
|
4.711
x
|
4.528
x
|
4.359
x
|
Free Cash Flow
1 |
884
|
918
|
575
|
-
|
-
|
572
|
1,384
|
1,795
|
ROE (net income / shareholders' equity)
|
8.17%
|
6.21%
|
2%
|
0.74%
|
1.49%
|
2.73%
|
3.61%
|
4.19%
|
ROA (Net income/ Total Assets)
|
3.87%
|
2.97%
|
1%
|
0.39%
|
0.83%
|
1.6%
|
2.3%
|
2.8%
|
Assets
1 |
31,861
|
32,932
|
33,698
|
36,405
|
40,951
|
45,744
|
43,976
|
42,868
|
Book Value Per Share
2 |
37.90
|
38.30
|
39.40
|
41.40
|
44.70
|
46.20
|
48.30
|
46.40
|
Cash Flow per Share
2 |
3.800
|
3.270
|
2.990
|
2.860
|
3.090
|
3.290
|
4.390
|
4.590
|
Capex
1 |
652
|
446
|
701
|
1,108
|
1,533
|
1,341
|
1,071
|
929
|
Capex / Sales
|
12.74%
|
9.69%
|
14.77%
|
18.9%
|
23.09%
|
17.22%
|
12.45%
|
9.44%
|
Announcement Date
|
2/12/20
|
2/9/21
|
2/15/22
|
2/15/23
|
2/13/24
|
-
|
-
|
-
|
Last Close Price
99.96
USD Average target price
105.7
USD Spread / Average Target +5.71% Consensus |
1st Jan change
|
Capi.
|
---|
| +10.86% | 59.77B | | -5.32% | 19.07B | | -3.84% | 13.4B | | +2.15% | 7.74B | | -7.31% | 5.89B | | +12.91% | 3.59B | | -6.52% | 3.04B | | +2.65% | 3.03B | | +15.65% | 2.8B | | -15.55% | 2.35B |
Healthcare REITs
|